6H-dibenzo [B, E] oxepine derived nonsteroidal mineralocorticoid receptor antagonists

Details for Australian Patent Application No. 2008343524 (hide)

Owner Eli Lilly and Company

Inventors Jadhav, Prabhakar Kondaji; Gavardinas, Konstantinos

Agent Spruson & Ferguson

Pub. Number AU-B-2008343524

PCT Pub. Number WO2009/085584

Priority 61/014,776 19.12.07 US

Filing date 9 December 2008

Wipo publication date 9 July 2009

Acceptance publication date 8 March 2012

International Classifications

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/4184 (2006.01)

A61P 5/40 (2006.01) Drugs for disorders of the endocrine system

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

8 July 2010 PCT application entered the National Phase

  PCT publication WO2009/085584 Priority application(s): WO2009/085584

8 March 2012 Application Accepted

  Published as AU-B-2008343524

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008343549-Seal for a dock leveler lip hinge

2008343510-Antimicrobial cellulose sponge and method of making